首页> 外文期刊>Journal of infection and public health. >Hepatitis C, hepatitis B and HIV infection among Egyptian prisoners: Seroprevalence, risk factors and related chronic liver diseases
【24h】

Hepatitis C, hepatitis B and HIV infection among Egyptian prisoners: Seroprevalence, risk factors and related chronic liver diseases

机译:埃及囚犯中的丙型肝炎,乙型肝炎和艾滋病毒感染:血清流行率,危险因素和相关的慢性肝病

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Background and aim: Prisons in Egypt do not currently screen for blood-borne viruses, and there are no statistics concerning the prevalence of hepatitis C virus, hepatitis B virus or human immunodeficiency virus among prisoners. This study was performed to detect the prevalence of antibodies against hepatitis C, hepatitis B core and human immunodeficiency virus among Egyptian prisoners. Methods: The study was conducted in an Egyptian prison. The prisoners voluntarily completed a risk factor questionnaire and provided blood specimens for testing for antibodies against hepatitis C virus, hepatitis B virus core antigen and human immunodeficiency virus. Positive results were confirmed by the detecting HCV RNA via polymerase chain reaction. Multivariate regression analysis was performed to determine the factors that were independently associated with positive HCV serology. Results: Five hundred resident prisoners were screened. The prevalence of hepatitis C virus antibodies was 15.8% (79/500), and viremia was confirmed by PCR in 77.2% (61/79) of the antibody-positive prisoners. The prevalence of antibodies to hepatitis B core antigen was 9.8% (49/500), and 1.2% (6/500) of prisoners were dually infected with HBV and HCV. Antibodies to human immunodeficiency virus were not detected in any of the prisoners. The best predictor for hepatitis C and hepatitis B infection was a history of intravenous drug use (. P<. 0.011 for HBV and P<. 0.001 for HCV), a period of >10 years spent in prison (. P<. 0.052 for HBV and P<. 0.021 for HCV) and shared toiletries (. P<. 0.059 for HBV and P<. 0.002 for HCV). Conclusion: Hepatitis C and hepatitis B virus infections constitute an important public health problem in prisons. Public health strategies to prevent morbidity and mortality from these infections should include hepatitis B vaccination, HCV testing, counseling and medical management of infected prisoners.
机译:背景和目的:埃及的监狱目前不筛查血液传播的病毒,也没有关于囚犯中丙型肝炎病毒,乙型肝炎病毒或人类免疫缺陷病毒流行的统计数据。进行这项研究是为了检测埃及囚犯中丙型肝炎,乙型肝炎核心和人类免疫缺陷病毒抗体的流行情况。方法:该研究在埃及监狱中进行。囚犯自愿填写了危险因素问卷,并提供了血液样本以检测抗丙型肝炎病毒,乙型肝炎病毒核心抗原和人类免疫缺陷病毒的抗体。通过聚合酶链反应检测HCV RNA证实了阳性结果。进行多变量回归分析以确定与HCV阳性血清学独立相关的因素。结果:筛选了500名居民囚犯。丙型肝炎病毒抗体的患病率为15.8%(79/500),通过PCR证实了77.2%(61/79)抗体阳性囚犯的病毒血症。乙型肝炎核心抗原抗体的患病率为9.8%(49/500),有1.2%(6/500)的囚犯被HBV和HCV双重感染。在所有囚犯中均未检出人类免疫缺陷病毒抗体。丙型肝炎和乙型肝炎感染的最佳预测指标是静脉使用药物的历史(HBV为。P <.0.011,HCV为P <.0.001),在监狱服刑超过10年(对于P..P <.0.052 HBV和HCV的P <0.021)和共用洗护用品(HBV的P <0.059,HCV的P <0.002)。结论:丙型肝炎和乙型肝炎病毒感染是监狱中的重要公共卫生问题。预防这些感染的发病率和死亡率的公共卫生策略应包括乙肝疫苗接种,HCV检测,对被感染囚犯的咨询和医疗管理。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号